DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 892 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,261,000 | +201.7% | 16,197 | +203.9% | 0.04% | +192.9% |
| Q3 2016 | $418,000 | -5.0% | 5,329 | +22.2% | 0.01% | -12.5% |
| Q2 2016 | $440,000 | +2.6% | 4,361 | -3.7% | 0.02% | -11.1% |
| Q1 2016 | $429,000 | -2.3% | 4,527 | -4.3% | 0.02% | -10.0% |
| Q4 2015 | $439,000 | +227.6% | 4,728 | +201.7% | 0.02% | +100.0% |
| Q3 2015 | $134,000 | -31.6% | 1,567 | -31.7% | 0.01% | -28.6% |
| Q2 2015 | $196,000 | +92.2% | 2,293 | +91.6% | 0.01% | +100.0% |
| Q1 2015 | $102,000 | +43.7% | 1,197 | +44.2% | 0.01% | -12.5% |
| Q4 2014 | $71,000 | +7.6% | 830 | -3.7% | 0.01% | 0.0% |
| Q3 2014 | $66,000 | -19.5% | 862 | -17.7% | 0.01% | -27.3% |
| Q2 2014 | $82,000 | -52.3% | 1,047 | -54.3% | 0.01% | -8.3% |
| Q1 2014 | $172,000 | +10.3% | 2,292 | +13.6% | 0.01% | -50.0% |
| Q4 2013 | $156,000 | -21.2% | 2,017 | -29.2% | 0.02% | -31.4% |
| Q3 2013 | $198,000 | +153.8% | 2,848 | +132.1% | 0.04% | +118.8% |
| Q2 2013 | $78,000 | – | 1,227 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |